<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-pharmaceuticals-14-00002">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Groome</surname>
    <given-names>L.J.</given-names>
   </name>
  </person-group>
  <article-title>Elevated Maternal Soluble Gp130 and IL-6 Levels and Reduced Gp130 and SOCS-3 Expressions in Women Complicated With Preeclampsia</article-title>
  <source>Hypertension</source>
  <year>2011</year>
  <volume>57</volume>
  <fpage>336</fpage>
  <lpage>342</lpage>
  <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.110.163360</pub-id>
  <?supplied-pmid 21173340?>
  <pub-id pub-id-type="pmid">21173340</pub-id>
 </element-citation>
</ref>
